Your English writing platform
Discover LudwigSimilar(60)
Even though the proportion of elderly (≥ 75 years) patients in the program has increased over time from 28% (1993 1994) to 37% in the current study years (1998 2002), PCP involvement among patients less than 65 years of age remains relatively higher given that among all cancer deaths in Nova Scotia, 46% are among those 75 years or older and only 26% less than 65 years of age [ 8].
Furthermore, participants of the Nurses Health Studyy and the Health Professional Follow-up Study were younger (30 75 years; mean age ~49 years) compared to those from the current study (>55 years; mean age 65.2 years).
Among all CVE types combined in the current study, first year inpatient costs were also higher for subsequent CVEs, but non-inpatient costs accounted for greater proportions.
The previous data included years 1980 2001, whereas the current study includes years 1987–2006.
The data from our previous study included years 1980 2001 whereas the current study included years 1987–2006.
In the current study, five-year cohorts extended from 1973 to the end of 1977 were used.
Mean age in the current study (66 years) was no different to other studies of patients with CKD in Taiwan, the UK and Italy (65 67 years) [ 52– 52].
The current study considered years of schooling (caregivers) as proxies for socioeconomic status in the assessment of independent negative impacts in the instrument.
For the current study, two years of cross-sectional data were pooled to gain an adequate sample size as recommended by MEPS designers [ 22].
The mean duration of RA was also shorter in the current study (0.3 years) versus the PREMIER study (0.7 0.8 years), although the percentage of patients who had previously taken DMARDs was higher (43.3 53.4% vs 31.5 32.5%).
Participants were weighed during the initial intervention at months 0 and 6, following completion of extended-care at month 18, and again for the current study 3.5 years after treatment (month 48).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com